City
Epaper

AMC detects 184 COVID patients in city

By Lokmat English Desk | Updated: April 9, 2021 22:05 IST

Aurangabad, April 9:The Aurangabad Municipal Corporation (AMC) health officials conducted 2,742 antigens and 3,414 RT-PCR tests (total of ...

Open in App

Aurangabad, April 9:

The Aurangabad Municipal Corporation (AMC) health officials conducted 2,742 antigens and 3,414 RT-PCR tests (total of 6,156 tests) at its COVID Care Centres (CCCs) and different places in the city and traced 184 Covid-19 patients today.

The health teams conducted 105 antigen tests at the CCCs and detected 33 persons as infected. The AMC personnel also held 1,166 RT-PCR tests at the CCCs. Meanwhile, by visiting different parts of the city, the mobile teams have conducted 2,543 antigen tests and detected 121 Coronavirus infected persons. They also collected swab samples of 1,820 suspects for RT-PCR tests.

According to AMC data, the Government Medical College and Hospital (GMCH) has conducted 77 RT-PCR tests, District Civil Hospital conducted 19 and private laboratories did 332 on Friday. The private laboratories also conducted 94 antigen tests and found 30 Coronavirus infected patients. The AMC will be receiving the reports of all RT-PCR tests tomorrow.

Tags: Government Medical College and Hospital, ChandigarhAurangabad municipal corporationAMCDistrict Civil Hospital
Open in App

Related Stories

MaharashtraMake India leading power in health care: President Droupadi Murmu

AurangabadASI to undertake scientific conservation of Malik Amber's tomb soon

Aurangabad2-year-old girl dies after boiling water falls on her

AurangabadCouple gets lifer for killing old man

Aurangabad19 passengers injured as bus rams into truck near Sawangi

Aurangabad Realted Stories

AurangabadSuperintendent, headmaster sent on leave after beating students

AurangabadFather slept forever; passes away a day after daughter’s wedding

AurangabadGoods worth ₹4.52 lakh stolen using crane, JCB

Aurangabad57 Pakistani nationals in city

AurangabadAther energy to launch IPO on April 28 for project development and R&D